 | • レポートコード：MRC308GR11526 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の処方減量薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の処方減量薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 処方減量薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
処方減量薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・経口錠剤、経口カプセル、注射剤
用途別セグメント
・病院、薬局
主要な市場プレーヤー
・Currax Pharmaceuticals (Contrave)、VIVUS (Qsymia)、Novo Nordisk A/S、Rhythm Pharmaceuticals (Imcivree)、Eli Lilly and Company (TRICARE)、CHEPLAPHARM (Xenical)、Pfizer、Teva Pharmaceutical (Actavis)、Haleon Group (alli)、Sanofi (Adlyxin)、AstraZeneca (BYDUREON BCise)
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、処方減量薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な処方減量薬メーカーの企業概要、2019年～2022年までの処方減量薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な処方減量薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別処方減量薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの処方減量薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での処方減量薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および処方減量薬の産業チェーンを掲載しています。
・第14、15章では、処方減量薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 処方減量薬の概要
– 種類別分析（2018年vs2022年vs2029年）：経口錠剤、経口カプセル、注射剤
– 用途別分析（2018年vs2022年vs2029年）：病院、薬局
– 世界の処方減量薬市場規模・予測
– 世界の処方減量薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Currax Pharmaceuticals (Contrave)、VIVUS (Qsymia)、Novo Nordisk A/S、Rhythm Pharmaceuticals (Imcivree)、Eli Lilly and Company (TRICARE)、CHEPLAPHARM (Xenical)、Pfizer、Teva Pharmaceutical (Actavis)、Haleon Group (alli)、Sanofi (Adlyxin)、AstraZeneca (BYDUREON BCise)
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：経口錠剤、経口カプセル、注射剤
・用途別分析2018年-2029年：病院、薬局
・処方減量薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・処方減量薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・処方減量薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・処方減量薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・処方減量薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Prescription Weight Loss Pills
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Prescription Weight Loss Pills Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral Tablets
1.3.3 Oral Capsules
1.3.4 Injections
1.4 Market Analysis by Application
1.4.1 Overview: Global Prescription Weight Loss Pills Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Global Prescription Weight Loss Pills Market Size & Forecast
1.5.1 Global Prescription Weight Loss Pills Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Prescription Weight Loss Pills Sales Quantity (2018-2029)
1.5.3 Global Prescription Weight Loss Pills Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Currax Pharmaceuticals (Contrave)
2.1.1 Currax Pharmaceuticals (Contrave) Details
2.1.2 Currax Pharmaceuticals (Contrave) Major Business
2.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product and Services
2.1.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Currax Pharmaceuticals (Contrave) Recent Developments/Updates
2.2 VIVUS (Qsymia)
2.2.1 VIVUS (Qsymia) Details
2.2.2 VIVUS (Qsymia) Major Business
2.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Product and Services
2.2.4 VIVUS (Qsymia) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 VIVUS (Qsymia) Recent Developments/Updates
2.3 Novo Nordisk A/S
2.3.1 Novo Nordisk A/S Details
2.3.2 Novo Nordisk A/S Major Business
2.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Product and Services
2.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novo Nordisk A/S Recent Developments/Updates
2.4 Rhythm Pharmaceuticals (Imcivree)
2.4.1 Rhythm Pharmaceuticals (Imcivree) Details
2.4.2 Rhythm Pharmaceuticals (Imcivree) Major Business
2.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product and Services
2.4.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
2.5 Eli Lilly and Company (TRICARE)
2.5.1 Eli Lilly and Company (TRICARE) Details
2.5.2 Eli Lilly and Company (TRICARE) Major Business
2.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product and Services
2.5.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eli Lilly and Company (TRICARE) Recent Developments/Updates
2.6 CHEPLAPHARM (Xenical)
2.6.1 CHEPLAPHARM (Xenical) Details
2.6.2 CHEPLAPHARM (Xenical) Major Business
2.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product and Services
2.6.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 CHEPLAPHARM (Xenical) Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Prescription Weight Loss Pills Product and Services
2.7.4 Pfizer Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 Teva Pharmaceutical (Actavis)
2.8.1 Teva Pharmaceutical (Actavis) Details
2.8.2 Teva Pharmaceutical (Actavis) Major Business
2.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product and Services
2.8.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Teva Pharmaceutical (Actavis) Recent Developments/Updates
2.9 Haleon Group (alli)
2.9.1 Haleon Group (alli) Details
2.9.2 Haleon Group (alli) Major Business
2.9.3 Haleon Group (alli) Prescription Weight Loss Pills Product and Services
2.9.4 Haleon Group (alli) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Haleon Group (alli) Recent Developments/Updates
2.10 Sanofi (Adlyxin)
2.10.1 Sanofi (Adlyxin) Details
2.10.2 Sanofi (Adlyxin) Major Business
2.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Product and Services
2.10.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sanofi (Adlyxin) Recent Developments/Updates
2.11 AstraZeneca (BYDUREON BCise)
2.11.1 AstraZeneca (BYDUREON BCise) Details
2.11.2 AstraZeneca (BYDUREON BCise) Major Business
2.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product and Services
2.11.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 AstraZeneca (BYDUREON BCise) Recent Developments/Updates
3 Competitive Environment: Prescription Weight Loss Pills by Manufacturer
3.1 Global Prescription Weight Loss Pills Sales Quantity by Manufacturer (2018-2023)
3.2 Global Prescription Weight Loss Pills Revenue by Manufacturer (2018-2023)
3.3 Global Prescription Weight Loss Pills Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Prescription Weight Loss Pills by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Prescription Weight Loss Pills Manufacturer Market Share in 2022
3.4.2 Top 6 Prescription Weight Loss Pills Manufacturer Market Share in 2022
3.5 Prescription Weight Loss Pills Market: Overall Company Footprint Analysis
3.5.1 Prescription Weight Loss Pills Market: Region Footprint
3.5.2 Prescription Weight Loss Pills Market: Company Product Type Footprint
3.5.3 Prescription Weight Loss Pills Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Prescription Weight Loss Pills Market Size by Region
4.1.1 Global Prescription Weight Loss Pills Sales Quantity by Region (2018-2029)
4.1.2 Global Prescription Weight Loss Pills Consumption Value by Region (2018-2029)
4.1.3 Global Prescription Weight Loss Pills Average Price by Region (2018-2029)
4.2 North America Prescription Weight Loss Pills Consumption Value (2018-2029)
4.3 Europe Prescription Weight Loss Pills Consumption Value (2018-2029)
4.4 Asia-Pacific Prescription Weight Loss Pills Consumption Value (2018-2029)
4.5 South America Prescription Weight Loss Pills Consumption Value (2018-2029)
4.6 Middle East and Africa Prescription Weight Loss Pills Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
5.2 Global Prescription Weight Loss Pills Consumption Value by Type (2018-2029)
5.3 Global Prescription Weight Loss Pills Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
6.2 Global Prescription Weight Loss Pills Consumption Value by Application (2018-2029)
6.3 Global Prescription Weight Loss Pills Average Price by Application (2018-2029)
7 North America
7.1 North America Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
7.2 North America Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
7.3 North America Prescription Weight Loss Pills Market Size by Country
7.3.1 North America Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
7.3.2 North America Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
8.2 Europe Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
8.3 Europe Prescription Weight Loss Pills Market Size by Country
8.3.1 Europe Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
8.3.2 Europe Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Prescription Weight Loss Pills Market Size by Region
9.3.1 Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Prescription Weight Loss Pills Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
10.2 South America Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
10.3 South America Prescription Weight Loss Pills Market Size by Country
10.3.1 South America Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
10.3.2 South America Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Prescription Weight Loss Pills Market Size by Country
11.3.1 Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Prescription Weight Loss Pills Market Drivers
12.2 Prescription Weight Loss Pills Market Restraints
12.3 Prescription Weight Loss Pills Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Prescription Weight Loss Pills and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prescription Weight Loss Pills
13.3 Prescription Weight Loss Pills Production Process
13.4 Prescription Weight Loss Pills Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Prescription Weight Loss Pills Typical Distributors
14.3 Prescription Weight Loss Pills Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Prescription Weight Loss Pills Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Prescription Weight Loss Pills Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Currax Pharmaceuticals (Contrave) Basic Information, Manufacturing Base and Competitors
Table 4. Currax Pharmaceuticals (Contrave) Major Business
Table 5. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product and Services
Table 6. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Currax Pharmaceuticals (Contrave) Recent Developments/Updates
Table 8. VIVUS (Qsymia) Basic Information, Manufacturing Base and Competitors
Table 9. VIVUS (Qsymia) Major Business
Table 10. VIVUS (Qsymia) Prescription Weight Loss Pills Product and Services
Table 11. VIVUS (Qsymia) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. VIVUS (Qsymia) Recent Developments/Updates
Table 13. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 14. Novo Nordisk A/S Major Business
Table 15. Novo Nordisk A/S Prescription Weight Loss Pills Product and Services
Table 16. Novo Nordisk A/S Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novo Nordisk A/S Recent Developments/Updates
Table 18. Rhythm Pharmaceuticals (Imcivree) Basic Information, Manufacturing Base and Competitors
Table 19. Rhythm Pharmaceuticals (Imcivree) Major Business
Table 20. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product and Services
Table 21. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
Table 23. Eli Lilly and Company (TRICARE) Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly and Company (TRICARE) Major Business
Table 25. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product and Services
Table 26. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Eli Lilly and Company (TRICARE) Recent Developments/Updates
Table 28. CHEPLAPHARM (Xenical) Basic Information, Manufacturing Base and Competitors
Table 29. CHEPLAPHARM (Xenical) Major Business
Table 30. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product and Services
Table 31. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. CHEPLAPHARM (Xenical) Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Prescription Weight Loss Pills Product and Services
Table 36. Pfizer Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. Teva Pharmaceutical (Actavis) Basic Information, Manufacturing Base and Competitors
Table 39. Teva Pharmaceutical (Actavis) Major Business
Table 40. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product and Services
Table 41. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Teva Pharmaceutical (Actavis) Recent Developments/Updates
Table 43. Haleon Group (alli) Basic Information, Manufacturing Base and Competitors
Table 44. Haleon Group (alli) Major Business
Table 45. Haleon Group (alli) Prescription Weight Loss Pills Product and Services
Table 46. Haleon Group (alli) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Haleon Group (alli) Recent Developments/Updates
Table 48. Sanofi (Adlyxin) Basic Information, Manufacturing Base and Competitors
Table 49. Sanofi (Adlyxin) Major Business
Table 50. Sanofi (Adlyxin) Prescription Weight Loss Pills Product and Services
Table 51. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Sanofi (Adlyxin) Recent Developments/Updates
Table 53. AstraZeneca (BYDUREON BCise) Basic Information, Manufacturing Base and Competitors
Table 54. AstraZeneca (BYDUREON BCise) Major Business
Table 55. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product and Services
Table 56. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. AstraZeneca (BYDUREON BCise) Recent Developments/Updates
Table 58. Global Prescription Weight Loss Pills Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Prescription Weight Loss Pills Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Prescription Weight Loss Pills Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Prescription Weight Loss Pills, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Prescription Weight Loss Pills Production Site of Key Manufacturer
Table 63. Prescription Weight Loss Pills Market: Company Product Type Footprint
Table 64. Prescription Weight Loss Pills Market: Company Product Application Footprint
Table 65. Prescription Weight Loss Pills New Market Entrants and Barriers to Market Entry
Table 66. Prescription Weight Loss Pills Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Prescription Weight Loss Pills Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Prescription Weight Loss Pills Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Prescription Weight Loss Pills Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Prescription Weight Loss Pills Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Prescription Weight Loss Pills Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Prescription Weight Loss Pills Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Prescription Weight Loss Pills Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Prescription Weight Loss Pills Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Prescription Weight Loss Pills Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Prescription Weight Loss Pills Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Prescription Weight Loss Pills Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Prescription Weight Loss Pills Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Prescription Weight Loss Pills Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Prescription Weight Loss Pills Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Prescription Weight Loss Pills Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Prescription Weight Loss Pills Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Prescription Weight Loss Pills Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Prescription Weight Loss Pills Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Prescription Weight Loss Pills Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Prescription Weight Loss Pills Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Prescription Weight Loss Pills Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Prescription Weight Loss Pills Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Prescription Weight Loss Pills Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Prescription Weight Loss Pills Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Prescription Weight Loss Pills Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Prescription Weight Loss Pills Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Prescription Weight Loss Pills Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Prescription Weight Loss Pills Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Prescription Weight Loss Pills Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Prescription Weight Loss Pills Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Prescription Weight Loss Pills Raw Material
Table 126. Key Manufacturers of Prescription Weight Loss Pills Raw Materials
Table 127. Prescription Weight Loss Pills Typical Distributors
Table 128. Prescription Weight Loss Pills Typical Customers
List of Figures
Figure 1. Prescription Weight Loss Pills Picture
Figure 2. Global Prescription Weight Loss Pills Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Prescription Weight Loss Pills Consumption Value Market Share by Type in 2022
Figure 4. Oral Tablets Examples
Figure 5. Oral Capsules Examples
Figure 6. Injections Examples
Figure 7. Global Prescription Weight Loss Pills Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Prescription Weight Loss Pills Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Pharmacy Examples
Figure 11. Global Prescription Weight Loss Pills Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Prescription Weight Loss Pills Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Prescription Weight Loss Pills Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Prescription Weight Loss Pills Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Prescription Weight Loss Pills Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Prescription Weight Loss Pills Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Prescription Weight Loss Pills by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Prescription Weight Loss Pills Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Prescription Weight Loss Pills Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Prescription Weight Loss Pills Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Prescription Weight Loss Pills Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Prescription Weight Loss Pills Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Prescription Weight Loss Pills Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Prescription Weight Loss Pills Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Prescription Weight Loss Pills Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Prescription Weight Loss Pills Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Prescription Weight Loss Pills Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Prescription Weight Loss Pills Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Prescription Weight Loss Pills Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Prescription Weight Loss Pills Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Prescription Weight Loss Pills Consumption Value Market Share by Region (2018-2029)
Figure 53. China Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Prescription Weight Loss Pills Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Prescription Weight Loss Pills Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Prescription Weight Loss Pills Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Prescription Weight Loss Pills Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Prescription Weight Loss Pills Market Drivers
Figure 74. Prescription Weight Loss Pills Market Restraints
Figure 75. Prescription Weight Loss Pills Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Prescription Weight Loss Pills in 2022
Figure 78. Manufacturing Process Analysis of Prescription Weight Loss Pills
Figure 79. Prescription Weight Loss Pills Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source